Reneo Pharmaceuticals Inc (RPHM)
1.73
-0.01
(-0.57%)
USD |
NASDAQ |
May 06, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
Reneo Pharmaceuticals Total Liabilities (Quarterly): 18.83M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.83M |
| September 30, 2023 | 15.44M |
| June 30, 2023 | 15.51M |
| March 31, 2023 | 11.78M |
| December 31, 2022 | 8.212M |
| September 30, 2022 | 10.46M |
| June 30, 2022 | 9.451M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.094M |
| December 31, 2021 | 6.813M |
| September 30, 2021 | 6.735M |
| June 30, 2021 | 3.753M |
| March 31, 2021 | 144.04M |
| December 31, 2020 | 97.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.753M
Minimum
Jun 2021
144.04M
Maximum
Mar 2021
27.50M
Average
10.46M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 397.95M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.44M |
| Shareholders Equity (Quarterly) | 88.61M |